Dianthus Therapeutics, Inc. (DNTH) stock
DNTHNasdaqPharmaceutical PreparationsFiscal year ends December 31
$91.81−0.67 (-0.72%)
Close on Nov 13, 2026Market cap $5.14BP/E –Yield 0.00%
Dianthus Therapeutics price to book ratio
The price-to-book ratio is market cap divided by shareholders' equity.
Dianthus Therapeutics's price to book ratio was 4.2× on Nov 11, 2026, against 3.4× a year earlier. Over the last 5 years it ranged from 0.2× to 7.7×, with a median of 1.9×.
Price to Book Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 4.2× | +0.9 |
| 2025 | Dec 31, 2025 | 3.2× | +1.3 |
| 2024 | Dec 31, 2024 | 1.9× | +1.0 |
| 2023 | Dec 29, 2023 | 0.9× | +0.6 |
| 2022 | Jan 31, 2022 | 0.2× | −0.1 |
| 2021 | Dec 31, 2021 | 0.3× | −0.2 |
| 2020 | Dec 31, 2020 | 0.6× | −0.3 |
| 2019 | Dec 31, 2019 | 0.9× | +0.6 |
| 2018 | Dec 31, 2018 | 0.3× | – |
See a number that looks wrong?